GB Patent

GB201200062D0 — Estradiol oromucosal liquid compositions

Assigned to INNOTESTO bvba · Expires 2012-02-15 · 14y expired

What this patent protects

The present invention relates to low dose estradiol solutions for oromucosal administration suitable in replacement therapy or suppletion of low estradiol levels and also for preventing, alleviating or treating symptoms associated with low endogenous levels of estradiol in female…

USPTO Abstract

The present invention relates to low dose estradiol solutions for oromucosal administration suitable in replacement therapy or suppletion of low estradiol levels and also for preventing, alleviating or treating symptoms associated with low endogenous levels of estradiol in female subjects.

Drugs covered by this patent

Patent Metadata

Patent number
GB201200062D0
Jurisdiction
GB
Classification
—
Expires
2012-02-15
Drug substance claim
No
Drug product claim
No
Assignee
INNOTESTO bvba
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.